It’s a great article and allows the people who are not very educated on OM to understand the possible value associated with an untapped indication. It also summarized current drugs in development. Just as Art said, IPIX is a clear leader in the race.
This is from that...”the aggregate of prevention and cutting SOM duration from 5.5 days to under 1 is nothing shy of impressive and essentially unparalleled by competitors...”